WebBreakpoint Therapeutics GmbH. Jul 2024 - Present3 years 10 months. Oxford, United Kingdom. Breakpoint Therapeutics is a spin-off of Evotec SE dedicated to the discovery of anti-cancer drugs that target the DNA Damage Response (DDR) in cancer cells. The company is advancing drug discovery programs initiated internally at Evotec to develop … WebJul 8, 2024 · ABOUT BREAKPOINT THERAPEUTICS GMBH. Breakpoint Therapeutics is a spin-off company of Evotec SE. The company is focused on the development of …
Breakpoint Therapeutics GmbH BIO-Europe
WebFind company research, competitor information, contact details & financial data for Breakpoint Therapeutics GmbH of Hamburg, Hamburg. Get the latest business insights from Dun & Bradstreet. WebAug 7, 2024 · German biotech group Evotec has once more launched a spin-off: Breakpoint Therapeutics GmbH is focusing on treating cancer patients by targeting DNA damage responses. As with the establishment of Topas Therapeutics in 2016, Hamburg-based Evotec is once more pooling various early-stage developmental projects and spinning … get your mc authority
Hannah Smith - Postdoctoral Research Associate - Breakpoint
WebBreakpoint Therapeutics GmbH 188 followers on LinkedIn. Modulating DNA damage responses to cure cancer By targeting the DNA damage response (“DDR”) in cancer cells, Breakpoint Therapeutics ... WebJul 8, 2024 · about breakpoint therapeutics gmbh Breakpoint Therapeutics is a spin-off company of Evotec SE. The company is focused on the development of several discovery projects in the area of DNA damage ... WebAug 7, 2024 · Evotec today announced the formation of Breakpoint Therapeutics GmbH, a spin-off company focusing on…. To continue reading The Pharma Letter please login , subscribe or claim a 7 day free trial subscription and access exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and … christophers eastgardens